Abstract
Introduction
Costs associated with colorectal cancer (CRC) are projected to be between $11.4 and $14 billion in 2020, creating a substantial burden for Medicare enrollees and the Medicare program (1) . Illness and death associated with CRC can be reduced through early detection and treatment. Four recommended tests for CRC screening of persons of average risk (2) are covered under Medicare: 1) annual fecal occult blood testing (FOBT); 2) sigmoidoscopy or 3) barium enema every 4 years; or 4) colonoscopy every 10 years. Despite having Medicare coverage for CRC tests, less than half of Medicare enrollees have received CRC tests at the recommended intervals (3) .
Much debate about health care reform centered on providing health insurance coverage to uninsured Americans. Although lack of insurance coverage is a leading reason for lack of access to health care, insurance coverage does not ensure access to health care. Aday et al (4) have used the term "realized access" to highlight the importance of factors in addition to insurance coverage and availability of providers that influence consumer access to health care, including the "transactions between patients and providers during the process of care delivery."
Physician influence on patients' CRC screening status is well documented. Physician recommendation has been associated with increased likelihood of screening (5, 6) , and the lack of recommendation has been identified as a barrier (7, 8) . Having a recent well visit (6) , being seen in group practices rather than solo practices (9) , and visiting internal medicine physicians rather than other primary care providers (10) have all been linked with increased CRC testing. Understanding physicians' influence on the CRC screening status of Medicare enrollees is, however, complicated by the fragmented care received by most Medicare enrollees. One study showed that most Medicare enrollees see 7 physicians in 4 practices in a given year (9) .
The objective of this study was to examine the role of physician visits among Medicare enrollees with and without CRC testing -enrollees who access this preventive service and enrollees with "unrealized access." Our aim was to identify potential opportunities to increase CRC testing in the untested population.
Methods

Study population
In this study, we included North Carolina We classified enrollees on the basis of specialties of the physicians they visited according to the following 7 categories: 1) only primary care physicians; 2) only nonprimary care physicians; 3) physicians with mixed specialties (1 of which was a primary care specialty); 4) both primary care and mixed-specialty physicians; 5) both primary care and nonprimary care physicians; 6) mixed-specialty and nonprimary care physicians; and 7) primary care, nonprimary care, and mixed-specialty physicians.
Statistical analyses
We (Table 3) . Enrollees without a test in 2005 were less likely than enrollees with a test to have received care from both primary care and nonprimary care physicians (17% vs 24%) and from physicians with primary care, nonprimary care, and mixed specialties (10% vs 18%).
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Of all Medicare patients who received care from at least 3 different types of physicians (primary care, nonprimary care, and mixed-specialty physicians), only half had a CRC test in 2005 ( Figure 1 ). Less than one-third of patients who had only primary care, nonprimary care, or mixedspecialty visits had a CRC test.
Medicare patients with obstetrician/gynecologist visits were most likely to be tested in 2005 (47%), followed by patients who had seen physicians with multiple specialties (Figure 2 ). Patients who had visits with family or general practice physicians were least likely to be tested (29% In all 3 models, demographic characteristics were significantly associated with receipt of CRC test. Medicare enrollees who were older, minority race or Hispanic ethnicity, or male were less likely to be tested. Enrollees originally eligible because of disability and those entitled to state buy-in (a marker for low income) were also less likely to have had a CRC test. Enrollees with evidence of any comorbid conditions were less likely to have had a CRC test. State variation was also observed: enrollees from South Carolina were more likely to have had CRC tests than those from North Carolina. As a stand-alone strategy, encouraging enrollees to visit primary care physicians may not result in substantial improvements in CRC testing at the population level (20) . In our cohort, many enrollees remained untested regardless of the frequency of visits. Our findings are consistent with earlier studies reporting that contact with physicians is not sufficient to ensure that CRC testing will be completed (5, 15, 21, 22) . Greater understanding of tools and systems is needed to support physicians in the promotion of CRC testing. Factors identified as barriers to physicians offering CRC testing include the limited amount of time for a patient visit, competing priorities, and lack of office systems to facilitate screening (23) (24) (25) . Increased CRC screening referrals have been documented through the use of simple tools such as chart stickers and reminders (26) . A toolbox containing sample policies, reminder systems, and communication approaches is available from the National Colorectal Cancer Roundtable to assist physicians in increasing CRC testing (www.nccrt.org).
Physician attitudes toward cancer screening may vary by specialty. The higher rate of CRC testing we found among enrollees with an obstetrician/gynecologist visit is consistent with findings from an earlier study showing significantly higher rates of mammography referral for patients treated by obstetrician/gynecologists compared with other primary care physicians (27) .
Although strategies to improve CRC testing typically target primary care physicians (28, 29) , we found that a combination of primary care and specialist visits was associated with increased CRC testing. A recent study reported that specialists spend a substantial portion of their time providing routine care and preventive services to their patients (30) . Electronic health records (EHRs) offer potential for improving CRC testing among all physicians, including specialists, by alerting physicians to patients' test status. EHRs could identify and recall patients for screening, remind office staff to counsel patients about screening, and monitor screening compliance. An EHR system with the ability to exchange information across settings may be the only feasible way to manage the multiplicity of communication that needs to occur between the many physicians providing care to Medicare enrollees.
Study limitations and strengths
CRC testing rates are known to vary by geographic region (3, 31, 32) . Different patterns may be observed in other locations. Current US Preventive Services Task Force recommendations on CRC screening recommend against routine screening of people aged 76 to 85 (33) . We included this age group in this study because we were targeting unscreened Medicare enrollees. CRC testing for some enrollees in this age group may not be appropriate. Medicare enrollees who had colonoscopy during 1996 through 1997 would be incorrectly classified in our data as untested. Medicare did not cover screening for CRC during that time period, and diagnostic test use was low. The effect of these data limitations is minimal, as our population-based rates compare favorably with rates from national surveys (3,34).
Conclusions
Increased CRC screening would reduce CRC death, but much work remains to be done to realize that benefit. Working with the Medicare population to increase "realized" access for those with insurance may inform approaches to access as we move toward health insurance reform. Abbreviations: OR, odds ratio; CI, confidence interval; NA, not applicable because variable not included in the model. a For Model 1, the association between number of visits and receipt of colorectal cancer testing was examined among all enrollees. b For Model 2, the association between number of visits and physician specialty were examined only for enrollees who had 1 or more physician visits. c For Model , the association between number of visits and the type of primary care provider seen was examined for enrollees who had primary care visits. d State buy-in indicates the enrollee is eligible for Medicaid to "buy" Medicare coverage. e Classified using Charlson index (11) modified for use with claims data. Categories indicate the number of Charlson conditions identified. Unknown indicates insufficient claims available to assess comorbidity. f Physician categories: 1) primary care: internal medicine, family medicine, general practice, preventive medicine, geriatric medicine, obstetrians/gynecologists, nurse practitioners and physician assistants; 2) mixed specialty: physicians with more than 1 specialty listed, 1 of which was a primary care specialty; ) nonprimary care: physicians with only nonprimary care specialties. 
